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Non-Syndromic Autosomal Recessive Deafness in Gaza Strip: A study 
on Selected Connexin 26 Gene Mutations 
Abstract 
 
Hearing loss (HL) is a common and highly heterogeneous sensory disorder which 
affects approximately 1 in 1000 infants. Genetic causes are thought to be responsible for 
more than 60% of the cases with the majority of non-syndromic HL being inherited in 
an autosomal recessive pattern. The gene first identified in 1997 to be associated with 
non syndromic autosomal recessive deafness (NSARD) was Gap junction beta 2 (GJB2) 
which codes for Connexin 26 (Cx26). Gap junction protein belongs to a family of 
transmembrane proteins with about 20 members in humans. Cx26, has been shown to 
play a key role in potassium homeostasis, which is essential for sound transduction. 
The aim of this study was to study the mutations in Cx26 gene in families with 
NSARD in Gaza strip. 
Descriptive analytical design was used to conduct this study and samples selected 
from three HL institutions in Gaza strip. 
The patients were screened for five GJB2 gene mutations namely, 35delG, 
167delT,  IVS1+1G>A, W77R and 235delC. First, the 35delG and 167delT mutations 
were screened using restriction enzyme analysis of the corresponding PCR products. 
Second, when no 35delG or 167delT mutations was detected, screening was continued 
for the IVS1+1G>A, 235delC  and W77R mutations.  
Our results revealed that GJB2 mutations contributed to 44.3% of the NSARD with 
allele frequency of 0.4%. The mutations were identified in either heterozygous or 
homozygous form. The most frequently encountered mutation was 35delG which 
accounted for 35.7% of the NSARD in either heterozygous (1.4%) or homozygous 
(34.3%) and represented about 80.5% of all mutations detected in this study. The 
second detected mutation was 235delC which accounted for 8.6% of NSARD and was 
recorded in only heterozygous form. The third mutation was IVS1+1G>A which was 
identified in only one proband (1.4%) in a compound heterozygous form along with 
35delG, Whereas, 167delT and W77R were not observed in our samples.  
We concluded that there is a significant contribution of GJB2 mutations to 
congenital NSARD in the Palestinian population of Gaza strip. Screening for GJB2 
iii 
 
mutations particularly, 35delG, 235delC and IVS1+1G>A should be offered to NSARD 
patients to confirm diagnosis of their congenital deafness, to deliver proper genetic 
counseling for the affected individuals and their families and to provide the patients the 
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غير الالصمم الوراثي المتنحي المسؤول عن  62في جين الكونكسين  المتعمقة الطفراتدراسة   
 مرتبط بمتالزمة في قطاع غزة
ملخصال  
% من 61. ولكن سنوياً  من المواليد 1111لكل  1فقدان السمع ىو خمل حسي شائع متعدد األسباب حيث يصيب حوالي 
 تعزى ألسباب وراثية وخاصة فقدان السمع الغير مرتبط بمتالزمة والذي يورث بصورة متنحية.الحاالت 
غير مرتبط بمتالزمة وىو جين اتصاالت ال السمع المتنحي تم تحديد أول جين لو عالقة قوية بفقدان 1997في سنة 
عن ممرات اتصال ينتمي لعائمة كبيرة من . ىذا البروتين عبارة 26 يشفر بروتين الكونكسين والذي )GJB2) 2 الفجوة بيتا
يمعب دور كبير في المحافظة عمى مستوى ممح  26 بروتين. بروتين الكونكسين 21بروتينات عبر غشائية والتي تتكون من 
ميما في توصيل الموجات الصوتية وتحويميا الى نبضات كيربائية ترسل عبر  البوتاسيوم في القوقعة والذي يمعب دوراً 
 لسمعي الى مركز السمع بالمخ.العصب ا
المتنحي  الوراثي بالصممالعائالت المصابة  في 26 الطفرات المؤثرة عمى جين الكونكسيندراسة  إلىتيدف ىذه الدراسة 
 غير مرتبط بمتالزمة في قطاع غزة.ال
 قطاع غزة.وىذه الدراسة من النوع الوصفي التحميمي، وتم جمع العينات فييا من ثالثة مؤسسات لمصم في 
 IVS1+1G>Aو 235delCو 167delTو  35delGتم فحص ىؤالء المرضى لدراسة خمسة أنواع من الطفرات وىي
تقنية التقطيع االنزيمي لنواتج  باستخدام 167delTو 35delG. حيث أنو في البداية تم البحث عن الطفرتين W77Rو
 في حالة عدم وجود الطفرتين استمر البحث عن الطفرات الثالثة األخرى. , ثانياً (PCR)الحامض النووي المتضخمة 
لخاص األليل ا% ونسبة وجود 44.3ساىمت بنسبة GJB2 أظيرت نتائج ىذه الدراسة بأن الطفرات المؤثرة في جين 
المواقح  ة( أو متخالف(homozygous% وىذه الطفرات موجودة إما عمى ىيئة متماثمة المواقح 1.4بيذا الجين كانت 
heterozygous) ً35في قطاع غزة ىي  (, وأكثر ىذه الطفرات شيوعاdelG  وىي موجودة عمى ىيئة 35.7حيث مثمت %
% من مجمل الطفرات التي 81.5مثمت ىذه الطفرة حوالي  و %1.4% ومتخالفة المواقح بنسبة 34.3متماثمة المواقح بنسبة 
%, 8.6حيث وجدت عمى ىيئة متخالفة المواقح بنسبة 235delC فكانت  شيوعاً أما ثاني طفرة تم تحديدىا في ىذه الدراسة, 
% عمى ىيئة 1.4حيث توجد في مريض واحد فقط بنسبة  IVS1+1G>Aفي قطاع غزة كانت  بينما ثالث طفرة شيوعاً 
 .W77Rو  167delT أظيرت النتائج بخمو العينات من الطفرتين . وأيضاً 35delGطفرة المع  ةمتخالفة المواقح مركب
غير مرتبط بمتالزمة في ال بالصمم الوراثي المتنحي GJB2مساىمة كبيرة لطفرات جين  وجودفي النياية, لقد استنتجنا 
عمى األشخاص  جراؤهإيجب أن يتم 235delC وIVS1+1G>A و  35delGقطاع غزة. لذلك فحص ىذه الطفرات وخاصة
الصم الذين يعانون من ىذا المرض مما يساعد في الكشف المبكر عن ىذا المرض وتقديم االستشارة الوراثية المناسبة 
 .لألشخاص الصم وعائالتيم وكيفية التعامل بطريقة مناسبة مع ىؤالء األشخاص
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Hearing loss (HL) is the most prevalent form of sensory impairment in humans, with 
approximately 1 in 1000 infants being born with a serious hearing deficit (Shahin et al., 
2002). Hereditary HL (HHL) can be subdivided into two types: syndromic or 
nonsyndromic. The syndromic type is associated with other distinctive clinical features 
beyond deafness and accounts for 30% of HHL. The nonsyndromic type, in which HL is 
the only clinical manifestation, represents the other 70% (Matsunaga, 2009). Regarding 
nonsyndromic HL, autosomal recessive is the most frequent inheritance pattern, accounting 
for 75-85% of the cases (Snoeckx et al., 2005; Ibrahim et al., 2011). It is followed by 
dominant pattern (12-13%) and X-linked or mitochondrial inheritance that accounts for 2-
3% of the cases (Ibrahim et al., 2011). Previous studies defined at least 23 human non-
syndromic autosomal recessive deafness (NSARD) loci (Petersen and Willems, 2006). 
The different loci for the numerous forms of deafness have been called DFN (for 
deafness) and are numbered in chronological order of discovery. The first NSARD locus, 
DFNB1 was identified by Guilford et al in 1994 which accounts for at least 50% of this 
type of HL (Mukherjee et al., 2003). At chromosome 13q11-q12, DFNB1 locus comprises 
Gap Junction β-2 (GJB2) and Gap Junction β-6 (GJB6) genes that code for connexin 26 
(Cx26) and connexin 30 (Cx30), respectively (Rodríguez-Paris et al., 2011). 
Connexin 26 (Cx26) is one member of a family of related gap-junction channel 
forming proteins (Mukherjee et al., 2003). These gap junction proteins oligomerize as 
hexamers to form transmembrane channels called connexons. Connexons from the cell 
membranes interdigitate to form direct intercellular communications pathways, the gap 
junction channels (RamShankar et al., 2003). Some forms of connexin are expressed in a 
wide variety of tissue, whereas others are restricted to specific cell types. Turnover of 
connexins appears to be rapid, suggesting that the levels of most forms are dependent on 




Human connexins are classified either by molecular mass (26-59 kDa) or by sequence 
similarities into 3 groups: gap junction α (GJA), gap junction β (GJB) or gap junction γ 
(GJC). NSARD is caused by mutations in the gap junction genes encoding the β connexins 
(Mukherjee et al., 2003). 
GJB2, the gene encoding human Cx26 (hCx26), was the first gene to be linked to an 
autosomal recessive form of deafness, DFNB1 (Zonta et al., 2012). GJB2 gene has 5500 bp 
and a single coding exon, in a total of two exons. More than 200 different pathogenic 
mutations were identified in this gene that account for 10-40% of congenital HL (Falah et 
al., 2011; Tang et al., 2006). GJB2 mutation spectrum differs among various populations or 
even within a particular country. Therefore, it is necessary to establish the frequency of 
GJB2 mutations in any population (Bonyadi et al., 2011). 
Mutations at the DFNB1 locus can be classified in two groups: (i) those that affect the 
coding sequence of GJB2, and (ii) those that lie outside the coding sequence of GJB2 and 
affect the expression and/or regulation of this gene (Gandía et al., 2013). 
1.2 Objectives  
1.2.1 General Objective  
To study the mutations in Cx26 gene in families with NSARD in Gaza strip.  
1.2.2 Specific Objectives 
1. To perform screening for 5 mutations in Cx26 in two steps. First, the 35delG and 
167delT mutations are screened in the deaf patients. Second, when no 35delG or 
167delT mutation is detected, screening is continued for the 235delC, IVS1+1G>A 
and W77R mutations. 
2. To identify the prevalent GJB2 mutations contributing to NSARD in Gaza strip for 
future development of diagnostic tests. 
3. To compare the prevalence of detected mutations in Gaza strip with those recorded 






1.3 Significance  
Due to the high rate of consanguineous and assortative marriages, NSARD is a prevalent 
genetic disorder in Gaza strip. Hitherto, no previous studies investigated the gene 
mutations linked to NSARD in Gaza strip. Screening for mutations in Cx26 gene will be 
useful to identify the cause of deafness, develop suitable diagnosis and deliver appropriate 
genetic counseling to NSARD families. Moreover, through seeking preimplantation 
genetic diagnosis (PGD), families with known mutations may have the possibility of 













2                                         Chapter 2  
3                                  Literature Review 
2.1 Deafness    
Deafness is a sensory impairment which results in a partial or total loss in reception of 
sound. The intensity of sound can be measured in decibels (dB). It is usual to assess 
hearing thresholds at frequencies of 0.25, 0.5, 1, 2, 4 and 8 KHz. Sounds of each frequency 
are presented at different intensities to a subject and the response is recorded graphically as 
an audiogram. A loss in hearing is indicated if the threshold for perception of sound for 
any frequency is elevated by 10 dB or greater as compared to the defined standard value 
for each frequency (Naz, 2012). 
2.2 Anatomy and physiology of the inner ear 
The ear is located within the temporal bone and consists of three main structural 
components: the outer ear, the middle ear, and the inner ear. The ear’s main functions are 
amplification, transduction and encoding of the external mechanical input (sound) to an 
electrochemical output traveling to the brainstem nuclei and cortex. The outer and middle 
ears comprise the sound conductive system and are both gas filled compartments 
(Schuknecht, 1993). 
The inner ear, which resides in a bony cavity, is a fluid-filled organ composed of two 
major regions, the cochlea, which processes the auditory signal and the vestibular 
apparatus (utricle, saccule, and ampluae of the semicircular canals) which helps maintain 
balance by responding to gravity and acceleration (Figure 2.1) (Davis, 2003). 
The processing of auditory signals takes place in the cochlea, which is a bony canal that 
coils around it's central core called the modiolus, having 2.75 turns in humans. 
The cochlea subdivided into three large cavities, the scala vestibule and the scala tympani. 
Both of these cavities contain a liquid called perilymph that is similar in composition to 
cerebrospinal fluid. A third cavity, the scala media (cochlear duct), lies between the scala 
vestibuli and the scala tympani. The scala media, is a triangular membranous canal that is 
limited by the Reissner's membrane (top), the basilar membrane (bottom) and stria vascularis 




Figure 2.1 Diagram of the inner ear in cross-section of the human temporal bone (Forge and 
Wright, 2002). 
The molecular as well as physical and biological properties of the cochlear duct vary 
throughout its length and are reflected in differences and gradients of gene expression 
(Davis, 2003). 
The stria vascularis is an ion transporting epithelium composed of three cell types: 
marginal, intermediate, and basal cells. Together, they generate the high endolymphatic 
potassium ion concentration and positive endocochlear potential. The organ of Corti, 
which is the sensory transduction organ of the cochlea, rests just on top of the basilar 
membrane throughout the cochlear duct. The organ of Corti is comprised of hair cells, 
supporting cells, neurons, blood vessels and the tectorial membrane (Kessel and Kardon, 
1979; Schuknecht, 1993). 
The supporting cells include several different types of cells, most of which have a 
poorly understood function. It has been shown that the supporting cells function to recycle 
the potassium ions, form a sealed barrier between the endolymph and perilymph filled 
spaces, maintain the hair cell function, and structurally support the organ of Corti,  
specifically as the hair cells are in contact with supporting cells. The supporting cells are 
6 
 
coupled to each other by gap junctions (comprised of connexins 26, 30, 31 and 43, in the 
cochlea, and 26, 30 and 43, in the vestibular system), allowing them to act as a 'functional 
unit' (Forge et al., 2003). 
The hair cells of the cochlea are the sensory cells. At their apical surface lie bundles of 
stiff-actin filled microvilli, named stereocillia (Pickles et al., 1984; Furness and Hackney, 
1985). 
The hair cells of the cochlea are divided into inner and outer hair cells (IHCs and 
OHCs) that differ in their structure, pattern of innervation and function (Snoeckx et al., 
2005). 
The OHCs translate the changes in membrane potential into macroscopic changes in 
the length of their cell bodies, which is mediated by Prestin, a transmembrane protein 
located in the cell membrane of the outer hair cells (Zheng et al., 2000). This generates the 
mechanical energy that is required for amplifying the sound induced vibrations in the 
cochlea, which are largely responsible for hearing sensitivity and frequency  resolving 
capability of the ear (Dallos and Fakler, 2002). 
By contrast, IHCs function as the sensory receptors of the hearing organ and convey 
essentially all auditory information to the brain (Ottersen et al., 1998). 
2.3 Grades of HL 
HL may present itself with variable grades which are adapted from World Health 
Organization (WHO) in 2014 as described in (Table 2.1). Grades 2, 3 and 4 are classified 
as disabling hearing impairment. The audiometric International Organization for 
















25 dB or better 
(better ear) 
No or very slight 
hearing problems. Able 
to hear whispers. 
- 
1- Slight (Mild) 
26-40 dB      
(better ear) 
Able to hear and repeat 
words spoken in normal 
voice at 1 meter. 
Counseling. Hearing aids may be 
needed. 
2- Moderate 
41-60 dB      
(better ear) 
Able to hear and repeat 
words spoken in raised 
voice at 1 meter. 
Hearing aids usually 
recommended. 
3- Severe 
61-80 dB      
(better ear) 
Able to hear some 
words when shouted 
into better ear. 
Hearing aids needed. If no hearing 
aids available, lip-reading and 
signing should be taught. 
4- Profound                                       
…including 
....deafiness 
81 dB or greater     
(better ear) 
Unable to hear and 
understand even a 
shouted voice. 
Hearing aids may help 
understanding words. Additional 
rehabilitation needed. Lip-reading 
and sometimes signing essential. 
 
2.4 Classification of HL 
HL can be classified as conductive, sensorineural, or mixed HL, based on the anatomic 
location of the problem (site of lesion, i.e., middle or inner ear). HL may also be labeled as 
unilateral or bilateral, depending on whether the loss is in one (unilateral) or both 
(bilateral) ears. The degree of loss might be the same in both ears (symmetrical HL) or it 
could be different for each ear (asymmetrical HL) (Shemesh, 2010). 
Conductive HL (CHL) is characterized by an obstruction to air conduction that 
prevents the proper transmission of sound waves through the external auditory canal and/or 
the middle ear. It is marked by an almost equal loss of all frequencies. CHL may be 
congenital or caused by trauma, severe otitis media, otosclerosis, neoplasms, or atresia of 
the ear canal. Some CHL can be treated surgically with tympanoplasty or stapedectomy, 




Sensorineural HL (SNHL) occurs when the sensory receptors of the inner ear are 
dysfunctional. SNHL is a lack of sound perception caused by a defect in the cochlea and/or 
the auditory division of the vestibulocochlear nerve. This type of HL is more common than 
CHL and is typically irreversible. It tends to be unevenly distributed, with greater loss at 
higher frequencies. SNHL may result from congenital malformation of the inner ear, 
intense noise, trauma, viral infections, ototoxic drugs (e.g., cisplatin, salicylates, loop 
diuretics), fractures of the temporal bone, meningitis, cochlear otosclerosis, aging (i.e., 
presbycusis), or genetic predisposition, either alone or in combination with environmental 
factors. Many patients with SNHL can be habilitated or rehabilitated with the use of 
hearing aids. Patients with profound bilateral SNHL (e.g., at least 90 dB) who derive no 
benefit from conventional hearing aids may be appropriate candidates for the cochlear 
implant device, which bypasses the damaged structures of the cochlea and stimulates the 
function of the auditory nerve. Auditory brainstem implants, which are similar to 
multichannel cochlear implants, are used in patients with neurofibromatosis type 2 
following vestibular schwannoma removal, especially those individuals who have lost 
integrity of the auditory nerves (Shemesh, 2010).  
Individuals with mixed HL (MHL) have both conductive and sensory dysfunction. 
MHL is due to disorders that can affect the middle and inner ear simultaneously, such as 
otosclerosis involving the ossicles and the cochlea, head trauma, middle ear tumors, and 
some inner ear malformations. Trauma resulting in temporal bone fractures may be 
associated with CHL, SNHL and MHL (Shemesh, 2010). 
2.5 Mode of Inheritance 
The pattern of inheritance of monogenic prelingual non-syndromic deafness may be an 
autosomal dominant, autosomal recessive, X-chromosomal recessive or maternal trait 
(Smith and Hone, 2003). The percentage of prelingual HHL transmitted through an 
autosomal recessive trait is 75-80%, an autosomal dominant trait is 10-20%, X-linked is   
1-5%, or maternally inherited is 0-20% depending upon the investigated population 
(Petersen, 2002; Smith and Hone, 2003). 
NSARD is usually prelingual and stable and it is very rare to be post-lingual deafness. 
The autosomal recessive forms are usually more severe than the other forms and are 
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entirely due to cochlear defects. While non syndromic autosomal dominant deafness 
(NSADD) is commonly post-lingual and progressive (Schrijver, 2004). 
In a recessive inheritance, both inherited alleles have to be mutated to cause HL. The 
person is referred to as "Homozygous" or "heterozygous" for the mutation. The person 
may be "compound heterozygous" for the mutation. Carriers do not have HL (Bayazit and 
Yilmaz, 2006). 
The genotype-to-phenotype relation in HHL is important. In terms of HL, phenotype 
is the type of HL that can be figured out by means of an audiogram. Genotype means the 
mutation in the gene resulting in HL. The responsible genotype alteration or mutation can 
be better understood by looking at the phenotype or the type of HL (Bitner-Glindzicz, 
2002). 
Prefix DFN is derived from the term "deafness" and it is used to describe the locus 
responsible for genetic non-syndromic HL (NSHL). The abbreviation such as DFNA is 
used to present the autosomal dominant form, DFNB to the autosomal recessive form of 
HL, and DFN also represents X-linked NSHL. Numbers added after these abbreviations, 
like DFNB1 or DFNB30, represent the sequential order in which the loci are found 
(Bayazit and Yilmaz, 2006). 
2.6 Gap junction protein (connexin  protein) structure and assembly 
Gap junctions (GJs) or connexins are highly specialized membrane structures that contain 
clusters of channels. This organization requires the membranes of two neighboring cells to 
come close to each other leaving a 2-4 nm gap (Bruzzone et al., 1996).  
Connexins have a highly conserved form of transmembrane domains separating two 
extracellular loops from a middle cytoplasmic loop and the N- and C-terminal cytoplasmic 
ends (RamShankar et al., 2003). Connexins oligomerize with five other connexin 
molecules to form a connexon. Connexins are synthesized in the  endoplasmic reticulum 
(ER) and oligomerize in the ER/Golgi or trans-Golgi network to form connexons. 
Connexons are subsequently transported to the plasma membrane by vesicular carriers 
travelling along microtubules. Connexons in adjoining cells fuse through disulfide bonding 
to form GJs (Figure 2.2). The combination of several connexins lead to diverse connexons 
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and GJ channels with different properties according to the needs of each cell type (Iossa et 
al., 2011).  
 
Figure 2.2 A diagram illustrating basic structures of connexins and undocked hemichannels 
present at the cell surface. Adopted from (Orellana et al., 2011). 
Up to now, 21 connexins have been established in humans, each coding for a 
transmembrane protein with the same protein topology (Iossa et al., 2011). The crucial role of 
GJ-mediated intercellular communication (GJIC) for coordination of development, tissue 
function, and cell homeostasis is now well documented. In addition, recent findings have 
fueled the novel concepts that connexins, although redundant, have unique and specific 
functions, that GJIC may play a significant role in unstable, transient cell to cell contacts, and 
that GJ hemichannels by themselves may function in intra-/extracellular signaling (Segretain 
and Falk, 2004).  
Gap junction biosynthesis and assembly are strictly regulated and intercellular junctions 
have a short half-life of only a few hours (Musil et al., 2000). Assembly of these channels is a 
complicated, highly regulated process that includes biosynthesis of the connexin subunit 
proteins on ER membranes, oligomerization of compatible subunits into hexameric 
hemichannels (connexons), delivery of the connexons to the plasma membrane, head-on 
docking of compatible connexons in the extracellular space at distinct locations, arrangement 
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of channels into dynamic, spatially and temporally organized GJ channel aggregates (so-called 
plaques), and coordinated removal of channels into the cytoplasm followed by their 
degradation (Segretain and Falk, 2004).  
2.7 GJB2 (Cx26) structure 
GJB2 gene is located on DFNB1 locus on chromosome 13q12. GJB2 gene is also known as 
CX26, DFNA3, DFNA3A, DFNB1, DFNB1A, HID, KID, NSRD1, and PPK. The size 
of GJB2 is approximately 2.5 kb. It encodes GJB-2 protein, 26 kDa. It has about 226 
amino acids (Kelsell et al., 1997). The structure of the GJB2 gene, as well the structure of 
other gap junction genes, is simple (Figure 2.3). An untranslated exon 1 is separated by an 
intron of 3179 bp length from exon 2, containing the uninterrupted coding region and the 
3'-untranslated region (3'-UTR) (Iossa et al., 2011).  
 
Figure 2.3 GJB2 molecular structure and localization. GJB2 gene is localized in 13q11 
chromosome and it is composed of two exons: only the exon 2 is a coding one, adopted from (Iossa 
et al., 2011). 
2.8 Expression of Cx26 in inner ear 
In the inner ear, Cx26 is expressed in the supporting cells, stria vascularis, basement 
membrane, limbus, and spiral prominence of the cochlea. The sensory hair cells of cochlea 
allow potassium ions to pass through during the mechanosensory transduction process of 
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normal hearing. These potassium ions are recycled across the supporting cells and 
fibrocytes at the base of hair cells through the gap junctions of the stria vascularis and back 
to the K+ rich endolymph (Figure 2.4). It is believed that mutations in the GJB2 gene 
would lead to complete or partial loss of function of the Cx26 protein, interfering with 
recycling of potassium ions and thus hampering the normal process of hearing 
(RamShankar et al., 2003).  
 
Figure 2.4 Schematic representation of the cochlea, showing the location of its different structures. 
The K+ recycling pathway is indicated. Adopted from (Jentsch, 2000). 
2.9 Heterogeneity of Genetic HL 
About 300-500 genes are estimated to be necessary for hearing out of the 30,000-50,000 
human genes. Genetic HL is mostly caused by a mutation in a single gene, but it represents 
extreme genetic heterogeneity. Genotype-to-phenotype correlation is important because 
different mutations in the same gene can lead to different phenotypes. The same mutation 
in a single gene can cause syndromic, non-syndromic, recessive or dominant hearing loss 
(Friedman and Griffith, 2003). 
Despite this heterogeneity, mutations in the GJB2 gene are responsible for approxi-
mately 60% of NSARD, with a carrier frequency ranging between 2 and 5% depending on 
the ethnic group (Gasparini et al., 2000). 
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2.10 GJB2 mutations 
Despite extraordinary genetic heterogeneity, mutations in one gene, GJB2, which encodes 
the Cx26 protein and is involved in inner ear homeostasis, are found in up to 50% of 
patients with NSARD. Because of the high frequency of GJB2 mutations, mutation 
analysis of this gene is available as a diagnostic test in many countries (Snoeckx et al., 
2005). 
The clinical consequence of certain mutations in the Cx26 gene is exclusively HL 
(non-syndromic deafness), whereas with other mutations the deafness is part of a syndrome 
(Marziano et al., 2003). 
More than 100 recessive mutations of GJB2, nearly all affecting proper translation of 
the Cx26 protein, are currently known (Wilch et al., 2006; Bazazzadegan et al., 2011). 
The most frequent recessive Cx26 mutation is a single base deletion 35delG that 
results in a frameshift at the 12th amino acid and premature termination of the protein 
(White, 2000). This mutation accounts for more than two-thirds of identified mutations 
(Schrijver, 2004). It still remains to be determined why this mutation has a relatively high 
frequency, but it has been suggested that 35delG is located in a hypermutable region.
 
Both 
a local Chi consensus motif and a TGGGG sequence, which have been linked to β-globin 
gene mutations and to recombination in the immunogobulin genes, could play a role. If 
slippage and mispairing of strands during DNA synthesis determine the high incidence of 
this mutation, however, ethnic background should not contribute much to variation in 
frequency. Yet, the prevalence of 35delG seems to markedly vary between populations 
(Denoyelle et al., 1997). 
An alternative to the mutation hot-spot hypothesis has been offered by Van-Laer et al. 
(2001),
 
who proposed that the high frequency of this variant results from a common 
founder. Because the mutation is thought to be evolutionarily ancient, haplotype sharing is 
observed in a small chromosomal region only. Although these hypotheses seem to be 
contradictory, both phenomena could have contributed to the high allele frequency of this 
single mutation (Van-Laer et al., 2001).  
Other common recessive Cx26 mutations include nonsense mutations and small 
deletions/insertions (Table 2.2), most of which also lead to premature termination of 
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protein translation. Therefore, most of the frequently observed recessive mutations result in 
severely truncated connexin proteins that are unlikely to retain any channel activity and 
recessive HL may largely be a result of null mutations in Cx26 (White, 2000). 
Genetic diagnosis is difficult because 10-50% of the affected persons 
have GJB2 mutations in only a single allele. In 50% of these patients, a deletion can be 
found which shortens the GJB6 gene. Digenic relation is now known to be an important 
cause of deafness in individuals, carrying a single mutation at the GJB2 locus along with a 
deletion at the functionally related GJB6 locus (Castillo et al., 2003). 
Table 2.2 The most common recessive mutations of GJB2 gene. 
Name of mutation Nucleotide change Reference 
35delG Deletion of G at 35 Zelante et al., 1997 
167delT Deletion of T at 167 Bale et al., 1999 
235delC Deletion of C at 235 Fuse et al.,1999; Kudo et al., 2000 
IVS1+1G>A G to A at –3172 Brownstein and Avraham, 2009 
W77R T to C at 229 Carrasquillo et al., 1997 
W77X G to A at 231 Kelsell et al., 1997 
W24X G to A at 71 Kelsell et al., 1997 
W44X G to A at 132 Green et al., 1999 
E47X G to T at 139 Denoyelle et al., 1999 
G45E G to A at 134 Fuse et al.,1999; Kudo et al., 2000 
M34T T to G at 101 Kelsell et al., 1997 
M1V A to G at 1 Estivill et al., 1998 
Y65X C to G at 195 Estivill et al., 1998 
L79P T to C at 236 Hamelmann et al., 2002 
S85P T to C at 253 Park et al., 2000 
G12V G to T at 35 Rabionet et al., 2000 
L90P T to C at 269 Denoyelle et al., 1999; Murgia et al., 1999 
V95M G to A at 283 Kelley et al., 1998 
Q57X C to T at 169 Wilcox et al., 1999 




2.11 Contribution of GJB2 (Cx26) gene to HL 
Given the extraordinary genetic heterogeneity of NSHL, it was surprising to find that 
sequence variations at the GJB2 locus account for up to 50% of cases of NSARD in some 
populations. A recent model to explain this observation is based on the tradition of 
intermarriage between individuals with HL in some populations. A gradual increase in the 
proportion of HL due to a hypothetical autosomal recessive mutation would be a 
consequence of this assortative mating. More than 90 variants of the GJB2 gene have been 
reported, and many are rare. One variant generally predominates in any given population, 
such as 167delT in the Ashkenazi Jewish population, 35delG among Caucasians of 
northern European descent, 235delC in the Japanese population (Kenneson et al., 2002).  
In Bethlehem-Palestine, 48 independently ascertained probands with NSARD were 
evaluated for mutations in the Cx26 gene. Of the 48 deaf probands, 11 (23%) were 
homozygous or compound heterozygous for mutations in GJB2. Five different mutations 
were identified: IVS1+1G>A, 35delG, 167delT, T229C, 235delC. The most common of 
these mutations are 35delG and 167delT (Shahin et al., 2002).  
In Syria, a study performed to determine the prevalence of GJB2 gene mutations in a 
sample of forty-one patients with HL and direct DNA sequencing was used to analyze 
exon 2 of the GJB2 gene. Seven patients (17.07%) had at least one mutation. Five of these 
(71.43%) had the 35delG mutation, of which three were homozygous, whereas the other 
two cases were heterozygous. The other detected mutations were W77R in one case and 
167delT with R184P mutations that together occurred as compound heterozygous in 
another case (Mahayri and Monem, 2012). 
In Lebanon, 48 Lebanese pedigrees investigated with NSARD, 37 were Muslims, 10 
Christians, and one Druze. Nearly 92% (44) of them were consanguineous. Sixteen of 
these families were linked to the DFNB1 locus (33%). In 15 of them, affected subjects 
were homozygous for the 30delG mutation in the GJB2 gene. In the last one, a non-
consanguineous Christian Maronite family, affected subjects were compound 
heterozygotes for two novel mutations, a missense mutation, replacing arginine by 
histidine at codon 32 (R32H), and an insertion of an adenine in position 291 (291insA) 
creating a stop codon (Mustapha et al., 2001). 
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In Jordan, Sixty-eight unrelated Jordanian consanguineous families with at least two 
members having NSARD, were tested for mutations of the GJB2 gene by sequencing 
which revealed only the 35delG mutation, found at the homozygous state in 11 patients. It 
was not detected at the heterozygous state, and no other mutations of the gene were 
identified in any of the patients (Medlej-Hashim et al., 2002). 
In the Mediterraneans, analysis of  polymerase chain reaction (PCR) products from  
affected patients’ DNA showed two frameshift mutations in the Cx26 gene. Deletion of a 
G within a stretch of six Gs at position 35 of the GJB2 cDNA (mutation 35delG) leads to 
premature chain termination and is present in 63% of NSARD chromosomes. Deletion of a 
T at position 167 of GJB2 (mutation 167delT), also resulting in premature chain 
termination, was detected in another patient. In this study there were three patients 
heterozygous for mutation 35delG in whom there were no second mutation in the GJB2 
coding region. In addition, there were 12 subjects with deafness linked to the DFNB1 locus 
who failed to show GJB2 mutations. These results suggest that mutations may be located 
in other regions of the connexin gene or that they may occur in neighboring genes mapping 
to chromosome 13q11-q12 which may also be involved in congenital deafness (Zelante et 
al., 1997). 
In Egypt, ten patients from 10 different families with severe to profound HL were 
homozygous for the 35delG mutation. One patient of a family with NSARD had a 
heterozygous 35delG mutation combined with a heterozygous splice site mutation 
IVS1+1G>A. The 35delG mutation was the most common pathogenic mutation in this 
population (Snoeckx et al., 2005). 
A study on 20 families, presently residing in an Israeli-Arab village in the lower 
Galilee, in whom both parents have normal hearing and ascertained through one child with 
a significant hearing defect. Genetic mapping by two-point and multi-point linkage 
analysis in 10 candidate regions identified the segregating gene to be on human 
chromosome 13q11 (DFNB1). Haplotype analysis, using eight microsatellite markers 
spanning 15 cM in 13q11, suggested the segregation of two different mutations in this 
kindred: W77R and 35delG and affected individuals were homozygotes for either 
haplotype or compound heterozygotes (Carrasquillo et al., 1997). 
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In the Ashkenazi Jewish population, two frame-shift mutations in GJB2, 167delT and 
30delG, were observed in the families with NSARD. The prevalence of heterozygosity for 
167delT, which is rare in the general population, was 4.03%, and for 30delG the 
prevalence was 0.73%. The high frequency of carriers of mutations in GJB2 (4.76%) 
predicts a prevalence of 1 deaf person among 1765 people, which may account for the 
majority of cases of NSARD in the Ashkenazi Jewish population (Morell et al., 1998). 
In Morocco, genomic DNA was isolated from 81 unrelated Moroccan familial cases 
with moderate to profound NSARD and 113 Moroccan control individuals. Molecular 
studies were performed using PCR-mediated site directed mutagenesis assay (PSDM), 
PCR and direct sequencing to screen for GJB2, 35delG and del(GJB6-D13S1830) 
mutations. GJB2 mutations were found in 43.20% of the deaf patients. Among these 
patients 35.80% were 35delG/35delG homozygous, 2.47% were 35delG/wt heterozygous, 
3.70% were V37I/wt heterozygous, and 1 patient was E47X/35delG compound 
heterozygous. None of the patients with one or no GJB2 mutation displayed the common 
(GJB6-D13S1830) deletion. They found also that the carrier frequency of GJB2-35delG in 
the normal Moroccan population is 2.65% (Abidi et al., 2007). 
In Tunisia, a study performed to determine the relative frequency of GJB2 allele 
variants on 138 patients with congenital HL belonging to 131 families originating from 
different parts of Tunisia. GJB2 mutations were found in 39% of families (51/131). The 
most common mutation was 35delG accounting for 35% of all cases (46/131). Four 
identified mutations in this study have not been reported in Tunisia; V37I, 235delC, 
G130A and the splice site mutation IVS1+1G>A (0.76%). These previously described 
mutations were detected only in families originating from Northern and not from other 
geographical regions in Tunisia (Riahi et al., 2013).  
In Algeria, one hundred sixteen persons from fifty-eight families were tested by the 
method based on the principle of PSDM, followed by a Bsl1 digestion. Mutation 35delG 
was diagnosed in sixteen families (11 homozygotes and 5 heterozygotes). The low allelic 
frequency (17.24%) and low ratio of individuals homozygous (13.8%) and heterozygous 
(6.9%) for the 35delG mutation suggest that there are other mutations in the GJB2 gene or 




In the Kingdom of Saudi Arabia, consanguineous marriages are common practice and this 
is associated with a noticeably high frequency of inherited conditions affecting the 
resulting progeny, including NSARD.  The population covered in this study is likely to 
have a multiethnic background caused by decades of religious and economic migration to 
this region. A total of 12 reported GJB2 mutations were identified in 17 out of 109 
(15.59%) NSARD cases. Biallelic GJB2 mutations were identified in 11 out of the 109 
NSARD cases (10.09%), with 35delG being the most common (7/11, 63.63%). The 
remaining six patients were found to have monoallelic GJB2 mutations (Al-Qahtani et al., 
2010).  
A study performed on Kuwaiti patients to determine Cx26 gene mutations. Gene 
profiling and sequencing were performed to detect the presence and nature of Cx26 
mutation. Of the 100 patients, mutation of Cx26 gene was detected in 15 patients (15%), 9 
(60%) of which were heterozygous and 6 (40%) were homozygous. The remaining 85 
patients were negative for mutation Cx26. Of the 15 Cx26-positive cases, 12 (80%) 
resulted from 35delG mutation. Of the 9 heterozygous cases, 6 (66.6%) were positive for 
35delG while 3 (33.3%) were positive for 71G>A mutation. All 6 homozygous cases were 
positive for 35delG mutation (Al-Sebeih et al., 2014).  
A study performed to investigate the prevalence of mutations in the Cx26 (GJB2) gene 
in Omani population using both PCR-Restriction fragment length polymorphism (PCR-
RFLP) and direct DNA sequencing methods. Two common GJB2 gene mutations (35delG 
and 167delT) were screened in 280 healthy controls and 95 deaf patients using two 
different PCR-RFLP methods. To investigate other GJB2 mutations, they have amplified 
and sequenced DNA from 51 unrelated deaf patients and 17 control subjects. None of the 
samples studied, either by RFLP or sequencing, revealed any deafness associated 
mutations in the coding region of the GJB2 gene. These findings disagree with many 
reports on the GJB2 gene, describing various mutations as the cause of congenital 
recessive deafness (Simsek et al., 2001). 
In Iran, a study performed to investigate the prevalence of the GJB2 gene mutations 
using direct sequencing in 43 presumed NSARD subjects from 34 families in an Iranian 
population. Eleven different genetic variants were identified. GJB2-related deafness 
mutations (35delG, 235delC, W24X, R184P and IVS1+1G>A) were found in 9 of 34 
families (26.5%). The 35delG was the most common mutation found in 5 of 34 families 
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(14.7%). One novel variant (–3517G>A) was found  in the upstream region of the gene 
(Hamelmann et al., 2002). 
Another study in Iran performed to investigate the contribution of GJB2 to the 
NSARD in the Iranian population. One hundred sixty eight persons from 83 families were 
studied. GJB2-related deafness was diagnosed in 9 families (4, 35delG homozygotes; 3, 
35delG compound heterozygotes; 1, W24X homozygote; and 1, non-35delG compound 
heterozygote). The carrier frequency of the 35delG allele in this population was ~1% 
(1/83). Because the relative frequency of Cx26 mutations is much less than in the other 
populations, it is possible that mutations in other genes play a major role in NSARD in Iran 
(Najmabadi et al., 2002). 
In China, DNA specimens collected from 3004 patients with NSARD from 26 regions 
of China were screened for the 235delC mutation. The coding exon of the GJB2 gene was 
PCR amplified, followed by restriction enzyme digestion with ApaI and analysis by 
agarose gel. They showed that overall, 488 patients (16.3%) were determined to carry at 
least one 235delC mutant allele, with 233 (7.8%) homozygotes and 255 (8.5%) 
heterozygotes. Therefore, within the subpopulations examined, the frequency varies from 
0% to 14.7% for 235delC homozygotes and from 1.7% to 16.1% for heterozygotes. On the 
basis of this survey of the patient cohort as stated, Chinese patients with NSARD appear to 
have a relatively higher 235delC frequency than that of other Asian populations (Dai et al., 
2007). 
In Japan, a study performed to analyze mutation for GJB2 in Japanese NSHL patients 
compatible with recessive inheritance. It was confirmed that GJB2 mutations are an 
important cause of HL in this population, with three mutations, 235delC, Y136X, and 
R143W, were especially frequent. Of these three mutations, 235delC was most prevalent at 
73%. Surprisingly, the 35delG mutation, which is the most common GJB2 mutation in 
white subjects, was not found in this study (Abe et al., 2000).  
In Italy and Spain, DNA samples from 82 families with NSARD and from 54 
unrelated participants with apparently sporadic congenital deafness were obtained and the 
coding region of the GJB2 gene was analyzed for mutations.  Also 280 unrelated people 
from the general populations of Italy and Spain were tested for the frameshift mutation 
35delG. Forty-nine percent of participants with recessive deafness and thirty-seven percent 
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of sporadic cases had mutations in the GJB2 gene. The 35delG mutation accounted for 
85% of GJB2 mutations, six other mutations accounted for 6% of alleles, and no changes 
in the coding region of GJB2 were detected in 9% of DFNB1 alleles (Estivill et al., 1998). 
A study on one 174 unrelated patients with prelingual NSARD to assess the 
significance of a mutation, IVS1+1G>A, to the NSARD among Iranian Azeri Turkish 
patients. Thirty nine patients had only one identified mutated allele, whereas hundred and 
thirty five patients were negative for coding region of GJB2. All these patients were 
screened for IVS1+1G>A by applying PCR-RFLP assay. Among studied patients, nine 
compound heterozygotes with 35delG, 120delE, 235delC were identified. Additionally, six 
patients were detected with only one IVS1+1G>A mutated allele. In these patients, the 
other mutated allele was left unidentified. One patient was identified to be homozygous for 
IVS1+1G>A. Further studies carried out on parents of positive cases, showed that one of 
the healthy parents (mother) to be homozygous for IVS1+1G>A mutation. By self-report, 
this person had no HL, although it is possible that she has mild or moderate HL, which she 
is unable to detect. Her child was compound heterozygous (IVS1+1G>A/35delG) with 
profound deafness (Bonyadi et al., 2011). 
A study performed on 60 patients from mostly large Turkish families with NSARD. 
GJB2 mutations were found in 31.7% of the families, and the GJB2-35delG mutation 
accounted for 73.6% of all GJB2 mutations. The carrier frequency of GJB2-35delG in the 
normal Turkish population was found to be 1.17% (five in 429). In addition to the 
described W24X, 233delC, 120delE and R127H mutations, they  also identified a novel 
mutation, Q80R, in the GJB2 gene (Uyguner et al., 2003).  
In Pakistan, the Pakistani population has become an important resource for research 
on NSARD due to the availability of large extended and highly consanguineous pedigrees. 
Here is presented the first report on the prevalence of GJB2 variants in Pakistan. One 
hundred and ninety-six unrelated Pakistani families with NSARD were recruited for a 
study on the genetics of NSARD. DNA sequencing of the GJB2 coding region was done 
on two affected individuals per family. Homozygous putatively functional GJB2 variants 
were identified in 6.1% of families. None of the putatively functional GJB2 variants were 
observed in the compound heterozygous state. The six putatively causative variants noted 
were W77X, W24X, 167delT, R32H, 120delE, and L90P, with W77X and W24X being 
the most common (Santos et al., 2005). 
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In Korea, a study performed to estimate the carrier frequencies of 
three GJB2 mutations, including 235delC, V37I, and G45E, in the general Korean 
population. A standard questionnaire of self-reported HL was used to identify and recruit 
subjects. Screening for three mutations was performed using an allele-specific PCR, PCR-
RFLP, and direct DNA sequencing. A total of 1256 unrelated healthy individuals were 
analyzed in the present study. Of the 1256 individuals, 24 had GJB2 mutations; 11 were 
found to be heterozygous for 235delC, 11 were heterozygous and one was homozygous for 
V37I, and one was heterozygous for G45E. One individual had a compound heterozygous 
mutation of 235delC/V37I. The allele frequencies of 235delC, V37I and G45E mutations 
were 0.44%, 0.52% and 0.04%, respectively (Kim et al., 2011). 
In Indonesia, forty patients with NSARD were studied to detect the common 
frameshift mutation (235delC) of Cx26 gene by using the PCR-RFLP analysis. But the 
results reflect no 235delC mutation in these patients. The possible explanation was that 
235delC variant is not a cause of NSARD in Indonesia (Gaffar et al., 2009). 
In Taiwan, a study performed to determine the mutation spectrum of the Cx26 gene 
among 324 Taiwanese patients with prelingual deafness and the carrier rate of gene 
mutation in another 432 unrelated control subjects. The coding region of the Cx26 gene 
was sequenced in both directions to detect mutation in all 756 samples. Among the 756 
samples tested, 21 Cx26 variants were detected, including 7 novel ones. The 235delC 
mutation was the most common, accounting for 57.6% of the mutant alleles. Among 
patients, 48 (14.8%) had Cx26 gene mutations. In the control group, the carrier rate of 











Materials and Methods 
3.1 Materials 
3.1.1 Chemicals and Reagents  
Chemicals and reagents used in this study are shown in Table 3.1. All chemicals were of 
analytical and molecular biology grade. 
Table 3.1 Chemicals and reagents used in this study. 
# Reagent Supplier 
  1.  Wizard ® Genomic DNA Purification Kit Promega (Madison, USA) 
2. PCR Go Taq® Green Master Mix   Promega (Madison, USA) 
3. Agarose  Promega (Madison, USA) 
4. PCR primers Promega (Madison, USA) 
5. Nuclease free water Promega (Madison, USA) 
6. Ethidium bromide Promega (Madison, USA) 
7. Ethanol 70%  (Sigma USA) 
8. Absolute Isopropanol  (Sigma USA) 
 
3.1.2 Instruments and Disposables 
The important instruments and disposables used in the present study are listed in Table 3.2. 
3.2 Methodology 
3.2.1 Study Design 
The present study is a descriptive analytical design. 
3.2.2 Study Location 
Study subjects were selected from three Gaza Strip HL institutions and centers/societies  
(Mustafa Sadiq Rafii Secondary School for the Deaf, Atfaluna Society for the Deaf 
Children, Basma Center for Audiology & Speech Therapy). Experimental work was 
carried out at the Genetic Diagnosis lab of the Islamic University of Gaza.  
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Table 3.2 Instruments and disposables used in this study. 
# Instrument Manufacturer 
1. Thermal Cycler Eppendrof, Germany 
2. Electrophoresis chambers and tanks (horizontal) BioRad, USA 
3. Electrophoresis power supply BioRad, USA 
4. Microcentrifuge Sanyo, UK 
5. Microwave Oven L.G, Korea 
6. Digital balance AE adam, USA 
 7.     Freezer, refrigerator ORSO, pharml-spain 
 8. Micropipettes (0.1-2.5 μl / 0.5-10 μl / 5-50 μl / 20-200 μl / 100-1000 μl) Dragon-lab, USA 
9. Safety cabinet N-Biotek,Inc 
10. Gel documentation system Vision, Scie-Plas Ltd, UK 
11. Microfuge tubes for PCR-thin wall 0.2 ml capacity Labcon, USA 
12. Microfuge tubes-1.5 ml capacity Labcon, USA 
13. EDTA tubes Hy. Labs. Israel 
14. Disposable tips Labcon, USA 
 
3.2.3 Study population 
The study population consisted of 70 deaf patients living in different regions of Gaza strip. 
The participants were from both genders and their age ranged from 2-27 years old. Apart 
from their deafness the subjects did not have any other serious health problems.  
3.2.4 Ethical Considerations 
The study protocol was presented for approval to the Ministry of Education, Directorate of 
Education-West of Gaza and to the Administrations of the three centers where the patients 
were recruited from. Approval and consent of parents of patients was also taken (Annex 2). 
3.2.5 Instruments of the study 
a. Questionnaire 
b. Blood sample 
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3.2.6  Blood sample collection 
Peripheral blood samples (~2 ml) were collected in EDTA tubes from the 70 unrelated 
patients diagnosed as having NSARD. 
3.2.7 Exclusion criteria 
In order to ensure that HL in the study subjects is most probably of the autosomal recessive 
non-syndromic type, a questionnaire was prepared for each patient to help exclude other 
HL causes as listed in (Annex 3) such as: 
- Any event that preceded the deafness as swimming, showering, noise exposure, 
long term drug use (e.g. aminoglycosides) or trauma. 
- Any recent or past episode of disease or infection as viral infection, meningitis, 
diabetes and others. 
- Any event during mother’s pregnancy such as drugs intake, accident, infection, 
surgery or exposure to anesthesia. 
- Any event during mother’s delivery such as premature delivery, low birth weight 
infant, lack of oxygen during delivery or difficulty during delivery. 
-  Some types of birth control method that the family uses such as oral 
contraceptives.                       
 
3.2.8 Extraction of DNA  
Genomic DNA was prepared from peripheral blood lymphocytes using Wizard Genomic 
DNA Purification Kit (Promega, USA) according to the manufacturer's protocol, and 
stored at -20°C until use. Extracted DNA was used in screening for the selected mutations.  
3.2.9 Analysis of mutations by PCR 
Specific primer sequences listed in (Table 3.3) were used to amplify the fragments 
containing the mutation. Then PCR-RFLP was performed for detection all five mutations, 
amplification was carried out in a thermocycler as listed in (Table 3.4), and In each PCR 
reaction a negative control, in which DNA wasn’t added, was used to confirm the absence 





PCR products were analyzed by electrophoresis in a 1.5% agarose gel containing ethidium 
bromide, and the results were documented using a gel documentation system. 
3.2.11 Selected mutations 
In this study, samples were first screened for 35delG and 167delT mutations, when no 
35delG or 167delT mutations was detected in deaf patients, screening was continued for 
the 235delC, IVS1+1G>A and W77R mutations. 
We selected these mutations because population in Gaza strip is an extension of 
populations of neighboring Middle East countries (e.g., Lebanon, Syria and Jordan) and 







Table 3.3  Primer sequences and the restriction enzymes used for detection of the different mutations in GJB2 gene. 
Restriction 
enzyme 
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Table 3.4 Amplification protocol for detection the five mutations using thermal cycler. 
Mutation 
Protocol 
Initial denaturation No. of cycles Steps Final Extension 
35delG 95˚C for 5min 35 
95˚C for 40sec 
65˚C for 30sec 
72˚C for 1min 
 
72˚C for 2min 
 
167delT 94˚C for 5min 35 
94˚C for 15sec 
62˚C for 15sec 
72˚C for 30sec 
 
72˚C for 5min 
 
IVS1+1 G>A 95˚C for 5min 32 
95˚C for 30sec 
59˚C for 30sec 
72˚C for 30sec 
 
72˚C for 5min 
 
235delC 94˚C for 5min 35 
94˚C for 30sec 
60˚C for 30sec 
72˚C for 30sec 
 
72˚C for 5min 
 
W77R 94˚C for 5min 35 
94˚C for 30sec 
60˚C for 30sec 
72˚C for 30sec 
 























4.1 Questionnaire analysis 
Questionnaires were distributed in HL institutions and centers/societies in Gaza strip 
and were collected after being filled by the parents. Seventy patients were selected for 
this study who consisted of 37 (53%) males and 33 (47%) females. The age range of 
patients was 2-27 years, with an average age of 14.8 years. The patients were from 
different regions in Gaza strip as shown in (Table 4.1). 
The results of the questionnaire revealed that consanguineous marriage is common 
between parents of patients (76%), and that there is a relevant family history in the 
family of the father (34%) or the mother (33%). Additionally, about 90% of the patients' 
parents have normal hearing with at least three children in their pedigree suffering from 
deafness without any other obvious abnormality. Collected data allowed us to consider 
the patients as having NSARD. 
Table 4.1 Questionnaire results of the deaf patients. 




        Male 37 53% 
        Female 33 47% 
Educational level 
        Kindergarten and less 10 14.2% 
        Primary 16 22.8% 
        Preparatory 2 3% 
        Secondary 42 60% 
Marital status 
        Single 68 97% 









North   16 23% 
Centre       18 26% 
Gaza city     4 6% 
South 32 45% 
Consanguinity between the patient’s parents 
Yes 53 76% 
No 17 24% 
Hearing of  the patient’s  parents 
Deaf parents 7 10% 
Non deaf parents 63 90% 
Family history of deafness 
A relevant family history in the family of the father 24 34% 
A relevant family history in the family of the mother 23 33% 
 
4.2 GJB2 gene analysis  
After the completion of the questionnaire, we employed a simple molecular test for the  
GJB2 gene mutations and it should be of considerable help to those patients to 
understand the cause of having the deafness. 
Five different mutations in the GJB2 gene were screened: 35delG, 167delT,  
IVS1+1G>A, W77R and 235delC from seventy probands with NSARD. Screening for 
these five mutations in Cx26 was performed in two steps. First, the 35delG and 167delT 
mutations were screened in the deaf patients using restriction enzyme analysis of the 
PCR products. Second, when no 35delG or 167delT mutations were detected in deaf 
patients, screening was continued for the IVS1+1G>A, 235delC and W77R mutations. 
Of the 70 deaf probands, 31 (44.3%) were homozygous or compound heterozygous for 
these five mutations, and there were 39 (55.7%) probands with NSARD who failed to 
show any of these mutations. This analysis started by screening 35delG and 167delT 
mutations in probands, since they represent the most frequent mutations in Cx26 gene in 
a previously reported Palestinian population from Bethlehem (Shahin et al., 2002). 
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But in our study, the results reveal no 167delT or W77R mutation and the most 
frequent of these five mutation was 35delG as indicated in (Table 4.2). 
4.3 Allele frequency of the detected mutations among deaf patients 
Total allele frequency= Total mutant alleles∕ Total number of alleles 
                                  = (24×2+1×2+6)∕(70×2) 
                                  = 0.4% 
(Table 4.2) illustrates the allele frequency of the detected mutations among the deaf 
patients in this study. The results show that 35delG has the highest allele frequency. 
Table 4.2 Frequency of mutations in Cx26 in patients with NSARD in Gaza strip. 






IVS1+1G>A IVS1+1G>A/35delG 1 (1.4%) 0.007 
235delC 235delC/unknown 6 (8.6%) 0.043 
167delT Not detected  - - 
W77R Not detected - - 
Total 31(44.3%) 0.4 
 
4.4 Screening for the 35delG mutation  
35delG was the most common mutant allele in Cx26 in Gaza strip. After restriction 
analysis for 35delG mutation, 25 of the 70 probands (35.7%) were found to be either 
heterozygous (1.4%) or homozygous (34.3%) for this mutation. Heterozygosity was 
recorded in only one proband (proband no. 15) who is compound heterozygous for 
35delG/IVS1+1G>A. (Figure 4.1) illustrates a photo of agarose gel for 35delG 




Figure 4.1 A photo of ethidium bromide stained agarose gel for 35delG restriction 
analysis by BstI, M= DNA size marker (50 bp ladder), lane 1, 2 indicate wild-type 
samples for  35delG which has two bands of 69 bp and 20 bp size, lane 3, 4, 5 indicate 
homozygous samples with one band of 89 bp size, lane 6 indicates a heterozygous 
sample with two bands of 89 bp and 69 bp size. 
4.5 Screening for the 235delC mutation 
The second most prevalent GJB2 mutation was detected only in heterozygous form (one 
mutant copy) in six probands (8.6%), with no second mutation in the GJB2 coding 
region. (Figure 4.2) illustrates a photo of agarose gel for 235delC restriction analysis by 
ApaI. 
 
Figure 4.2 A photo of ethidium bromide stained agarose gel for 235delC restriction 
analysis by ApaI, M= DNA size marker (50 bp ladder), lanes 1, 2, 4, 5, 6 indicate wild-
type samples for 235delC with two bands of 262 bp and 148 bp size, lane 3 indicates a 
heterozygous sample for 235delC with three bands of 410 bp, 262 bp and 148 bp size. 
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4.6 Screening for the IVS1+1G>A mutation 
In this study, only one proband (1.4%) who is compound heterozygous for this mutation 
with 35delG mutation was detected. (Figure 4.3) illustrates an agarose gel for 
IVS1+1G>A restriction analysis by HphI. 
 
Figure 4.3 A photo of ethidium bromide stained agarose gel for IVS1+1G>A restriction 
analysis by HphI, M= DNA size marker (50 bp ladder), lanes 1, 2, 4, 5, 6 indicate wild-
type samples for IVS1+1G>A with two bands of 242 bp and 118 bp size, lane 3 indicate 
heterozygous sample for IVS1+1G>A with three bands of 360 bp, 242 bp and 118 bp 
size.  
4.7 Screening for the 167delT mutation 
In our study, none of the 70 samples showed the 167delT mutation, and this is indicated 
in the results of agarose gel which demonstrated that all samples were normal for this  
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Figure 4.4 A photo of ethidium bromide stained agarose gel for 167delT restriction 
analysis by MwoI, M= DNA size marker (50 bp ladder), lanes from 1-6 indicate wild 
type samples for 167delT with one band of 322 bp size. 
4.8 Screening for the W77R mutation 
As with 167delT the study also could not detect any W77R mutation in the 70 
investigated samples. This is indicated by agrose gel results which demonstrated that all 
samples were normal for this mutation and were not digested by MspI restriction 
enzyme (Figure 4.5). 
 
Figure 4.5 A photo of ethidium bromide stained agarose gel for W77R restriction 
analysis by MspI, M= DNA size marker (50 bp ladder), lanes from 1-6 indicate wild 
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HL is a common and highly heterogeneous sensory disorder. Genetic causes are thought 
to be responsible for more than 60% of the cases in developed countries (Petit et al., 
2001). In the majority of cases, NSHL is inherited in an autosomal recessive pattern 
(Friedman and Griffith, 2003). 
The gene first identified in 1997 to be associated with NSARD was GJB2. The 
most common cause of congenital, recessively inherited, sensorineural NSHL (Wilch et 
al., 2010).  
GJB2 gene codes for Cx26 which belongs to a family of transmembrane proteins 
with about 20 members in humans (Kelsell et al., 1997). Hexamers of connexins 
(connexons) are displayed in the plasma membrane. Docking of connexons on the 
surfaces of two adjacent cells results in the formation of intercellular gap junction 
channels (Willecke et al., 2002). Several different connexins, including Cx26, have been 
shown to participate in the complex gap junction networks of the cochlea (Forge and 
Wright, 2002; Cohen-Salmon et al., 2004). It has been postulated that these networks 
play a key role in potassium homeostasis, which is essential for the sound transduction 
mechanism (Kikuchi et al., 2000). 
In this study, we screened five mutations in the GJB2 gene in families with 
NSARD in Gaza strip, and the selection of these five mutations relied on their common 
presence in the West Bank and in the Middle East. 
Our results revealed that the GJB2 mutations were evident in 31 (44.3%) probands, 
this result is higher than most of the results reported in the neighboring countries and 
other ethnic groups as summarized in (Table 5.1). GJB2 mutations in Gaza strip 
NSARD population have the highest frequency among previous studies listed in this 
study especially in Palestine (Bethlehem) in which GJB2 mutations contributed to 23% 
of the NSARD (Shahin et al., 2002). But in some countries such as Oman, GJB2 
mutations were ruled out from being a cause of hereditary NSHL making genetic 
counseling for HL a difficult task to accomplish (Simsek et al., 2001). Therefore, every 
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country should screen and document their common NSARD mutations in order to 
deliver appropriate diagnosis and counseling.  
Table 5.1 Frequency of Cx26 mutations among deaf populations of different ethnic 
origin. 
Country N Frequency (%) Reference 
Korea 1256 1.9 Kim et al., 2011 
Ashkenazi Jews 546 4.76 Morell et al., 1998 
Pakistan 196 6.1 Santos et al., 2005 
Iran 168 11.0 Najmabadi et al., 2002 
Taiwan 756 14.8 Hwa et al., 2003 
Kuwait 100 15 Al-Sebeih et al., 2014 
Saudi Arabia 109 15.59 Al-Qahtani et al., 2010 
Jordan 68 16.2 Medlej-Hashim et al., 2002 
Syria 41 17.07 Mahayri and Monem, 2012 
Egypt 111 19.8 Mustapha et al., 2001 
Indonesia 120 20 Snoeckx et al., 2005 
Algeria 116 20.7 Ammar-Khodja et al., 2007 
Palestine (Bethlehem) 48 23.0 Shahin et al., 2002 
Japan 53 26.4 Sugata et al., 2002 
Turkey 60 31.7 Uyguner et al., 2003 
Lebanon 48 33.3 Mustapha et al., 2001 
Italy and Spain 54 37 Estivill et al., 1998 
Israeli Arab 75 38.7 Sobe et al., 2000 
Tunisia 138 39 Riahi et al., 2013 
Morocco 81 43.20 Abidi et al., 2007 
Gaza strip 70 44.3 Present study 
One mutation of this gene, namely 35delG (also known as 30delG), accounts for up to 
85% of NSARD in some populations (Kenneson et al., 2002). The mutation involves 
deletion in a stretch of six G nucleotides, which lies in codon 10, resulting in a 
frameshift; a glycine is converted to a valine at codon 12 and a stop codon is formed at 
codon 13 (Sobe et al., 2000). In fact, the 35delG mutation is thought to occur in a hot spot 
site for mutations (Denoyelle et al., 1997; Kelley et al., 1998; Morell et al., 1998). 
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In our study, three different GJB2 mutations were identified among the probands 
namely, 35delG, 235delC and IVS1+1G>A. And the most frequent, 35delG, which 
represented 80.5% of all mutations detected in this study, and accounted for 35.7%, 
which was found in either heterozygous (1.4%) or homozygous (34.3%) form. This 
result was higher than that previous reported in some Arab countries such as Jordan 
(13.6%) (Medlej-Hashim et al., 2002), Egypt (10.8%) (Snoeckx et al., 2005), Algeria 
(20.7%) (Ammar-Khodja et al., 2007) and Tunisia (35%) (Riahi et al., 2013) as listed in 
(Table 5.2).  
Also, 35delG mutation in this study has higher frequency than reported in previous 
study in Palestine (Bethlehem) which account for 14% (Shahin et al., 2002). 
Furthermore, 35delG mutation in Gaza strip has lower frequency than other Arab 
countries such as Morocco (35.80%) (Abidi et al., 2007), Saudi Arabia (63.63%) (Al-
Qahtani et al., 2010), Syria (71.43%) (Mahayri and Monem, 2012) and Kuwait (80%) 
(Al-Sebeih et al., 2014), and in some Mediterranean countries such as Italy and Spain in 
which 35delG account for 85% (Estivill et al., 1998). 
Although 35delG commonly found in the Caucasian and white populations, this 
mutation was not reported in Taiwanese (Wang et al., 2002), Korean (Kim et al., 2011) 
and Japanese populations (Abe et al., 2000). This indicates that among the founders of 
those Asian populations the GJB2 35delG mutation is rare. In the contrary, 235delC is 
the most highly reported mutation in those Asian populations as discussed below. This 
also illustrates an interesting widespread genetic phenomenon where the common 
mutations of the same disease are usually different in populations of distant ethnicities. 
The second most frequent mutation detected was 235delC, which is a frameshift 
mutation due to deletion of a single cytosine at position 235 and was described for the 
first time in Japan (Yuan et al., 2010). Also, it represents the most frequent known 
mutation in Asian populations (Hwa et al., 2003; Ohtsuka et al., 2003; Park et al., 
2003).  In our study, this mutation was detected in only heterozygous form in 8.6% of 
NSARD probands. This frequency is lower than that reported in Chinese (16.3%) (Dai 
et al., 2007), Japanese (73%) (Abe et al., 2000) and Taiwanese (57.6%) (Hwa et al., 
2003), where, this mutation represent the most frequent one in those populations. On the 
other hand, this result is higher than previous study performed in Palestine (Bethlehem) 
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Table 5.2 Frequency of 35delG mutation among deaf populations of different ethnic 
origin. 
Country Frequency (%) Reference 
Ashkenazi Jews            0.73 Morell et al., 1998 
Israel 2.5-4 Sobe et al., 2000 
Egypt 10.8 Snoeckx et al., 2005 
Jordan 13.6 Medlej-Hashim et al., 2002 
Palestine (Bethlehem) 14 Shahin et al., 2002 
Iran 14.3 Peyvandi et al., 2011 
Algeria 20.7 Ammar-Khodja et al., 2007 
Tunisia 35 Riahi et al., 2013 
Gaza strip 35.7 Present study 
Morocco 35.8 Abidi et al., 2007 
Saudi Arabia 63.63 Al-Qahtani et al., 2010 
Syria 71.43 Mahayri and Monem, 2012 
Turkey 73.6 Uyguner et al., 2003 
Kuwait 80 Al-Sebeih et al., 2014 
Italy and Spain 85 Estivill et al., 1998 
Lebanon 94 Mustapha et al., 2001 
by Shahin et al. (2002), where their results revealed that only one proband (2.08%) had 
the 235delC in a compound heterozygous form with 167delT (Shahin et al., 2002). 
This mutation, however, has not been detected in Indonesia (Gaffar et al., 2009) or 
Malaysia (Ruszymah et al., 2005). This indicates that 235delC does not contribute to 
GJB2-associated deafness in these populations. 
The third detected mutation was IVS1+1G>A (also known as –3170G>A). This 
splice site mutation is predicted to disrupt splicing, yielding no detectable mRNA 
(Shahin et al., 2002). However, not all genetic laboratories routinely test for this 
mutation, which lies outside the coding region of the GJB2 gene (Yuan et al., 2010). 
In our study, this mutation found only in one proband (1.4%), who is a compound 
heterozygous for IVS1+1G>A with 35delG. This result is the same as the one 
previously reported in Palestine (Bethlehem) (Shahin et al., 2002), Tunisia (Riahi et al., 
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2013) and Egypt (Snoeckx et al., 2005). The frequency of this mutation is lower than in 
Iranian Azeri Turkish where in those populations it was recorded as 4.9% (Bonyadi et 
al., 2011). 
Mutation 167delT is a frameshift mutation that involves deletion of a T at position 
167 of GJB2 and results in premature chain termination (Zelante et al., 1997). This 
mutation seems specific to Israeli Ashkenazi and Palestinian populations (Shahin et al., 
2002). Whereas in a previous study in Palestine, this mutation accounted for 8.3% and 
was detected in four probands (Shahin et al., 2002). In Ashkenazi Jews 167delT 
accounted for 4.03% (Morell et al., 1998). Also this mutation has been observed in 
some Arab countries such as Syria, where the mutation was encountered in 
heterozygous form in four probands (8%) and in compound heterozygous form in one 
family (2%) (Al-Achkar et al., 2011). 
In our study, this mutation was not found in the seventy investigated patients 
indicating that 167delT mutation is quite rare in our population and its involvement in 
NSARD in Gaza strip is not tangible.  
W77R (also known as 229T→C) is a missense mutation leading to substitution of 
arginine for tryptophan at codon 77 in the second transmembrane domain of GJB2 
(Shahin et al., 2002). This allele has been previously reported in an Israeli Arab family 
(Carrasquillo et al., 1997), and in Palestine (Bethlehm) where it was evident in only one 
proband (2.1%) who was homozygous for this mutation (Shahin et al., 2002). Moreover, 
the mutation was reported in one Syrian patient (Mahayri and Monem, 2012). Many 
other previous studies reported the lack of W77R mutation in their patients suggesting 
that this mutation is low in most populations. In the present study, this mutation was not 
recorded indicating that W77R mutation is low and its significance in NSARD in Gaza 
strip is not remarkable. 
Discrepancies between different studies in terms of the frequency and type of GJB2 
mutations associated with NSARD could be due to several reasons including: sample 
size (higher sample size increases the chance of detecting rare or exceptionally low 
mutations), precision of genotyping method employed, selection criteria of the patients 
investigated, rate of consanguineous marriage, and population genetic structure in terms 
of the type of circulating founder GJB2 mutations. 
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In more than half of the examined patients none of the five screened GJB2 
mutations could be detected. NSARD in those patients may be due to other GJB2 
mutations not tested in this study or due to mutations in other NSARD loci. 
In conclusion, there is a significant contribution of GJB2 mutations to congenital 
NSARD in the Palestinian population of Gaza strip. Screening for GJB2 mutations 
particularly, 35delG, 235delC and IVS1+1G>A should be offered to NSARD patients to 
confirm diagnosis of their congenital deafness, to deliver proper genetic counseling for 
the affected individuals and their families and to provide the patients the optimal 
management. Moreover, defining the mutation responsible for the disease and with the 
advent of PGD families with NSARD children can exploit this technique for having 














Conclusion and Recommendations 
 
6.1 Conclusion 
The present study focused on  screening  five mutations in GJB2 gene in families with 
NSARD in Gaza strip namely, 35delG, 167delT, 235delC, IVS1+1G>A and W77R. The 
results of this study can be summarized as follows: 
 GJB2 mutations contributed to 44.3% of NSARD in Gaza strip. 
 Among GJB2 mutations investigated in this study 35delG, 235delC and 
IVS1+1G>A were detected in the patients whereas 167delT and W77R were not 
observed and therefore their contribution to NSARD in Gaza strip is not 
significant. 
 In Gaza strip, the 35delG mutation is, as in many populations, proved to be the 
most prevalent in NSARD patients. It is the predominant founder mutation in our 
population. 
 The high level of homozygosity for 35delG observed in this study reflects could 
be due to consanguinity. The consanguinity rate in the present study population 
reached 76%. 
 In the present study, 235delC allele was detected only in a heterozygous form. 
The second mutation may be another GJB2 that was not screened for or less 
likely may be present in an entirely different locus. 
 IVS1+1G>A  was the third detected mutation in our patients and was evident in 
only one proband in compound heterozygous form with 35delG. 
 167delT and W77R mutations were not detected in our study indicating these 
mutations do not have a major contribution to NSARD in Gaza strip. 
 About half of the patients did not show any of the five screened GJB2 mutations.  
 Our findings indicate that screening for three mutations, 35delG, 235delC and 
IVS1+1G>A would allow the early diagnosis of about half of the NSARD cases 





 Confirming NSARD in patients before undertaking genetic analysis of GJB2 
gene. 
 Starting the GJB2 mutation analysis with 35delG, 235delC and IVS1+1G>A in 
NSARD patient genetic workup. 
 Screening for other known Cx26 mutations when NSARD patients do not show 
the above mentioned mutations. 
 Performing GJB2 DNA sequence analysis for NSARD patients lacking known 
mutations. 
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Annex 2. A copy of the consent form 
 بسم اهلل الرمحن الرحيم
 
الموضوع 
 طمب موافقة أولياء األمور
 قسم التحاليل الطبية، أقوم بعمل -بدرية فؤاد السماك، ممتحقة بالجامعة اإلسالمية بغزة في كمية الدراسات العميا: أسا الباحثة
: دراسة بعسوان
غير مرتبط بمتالزمة في قطاع ال المتنحي  الوراثيالصممالمسؤول عن  26  في جين الكونكسين المتعمقة الطفراتدراسة"
 " غزة
ها عمى األشخاص الصم في قطاع غزة، والتي ستعود بالفائدة عمى العائالت التي ؤوهي أول دراسة في هذا المجال يتم إجرا
فيها أشخاص مصابين بالصم، حيث تقوم هذه الدراسة بالكشف عن أسواع الطفرات التي تؤدي إلى فشل في وظيفة جين 
. في حاسة السمع  الذي يمعب دور كبير26الكوسكسين 
ن معرفة سوع  ومن المعموم أن الطفرات تختمف من إقميم ألخر والتي لم تحدد حتى اآلن في إقميم قطاع غزة، وا 
مما يساعد في عالج األشخاص المصابين بالصم والذي وفره لسا العمم  (المرحمة الجسيسية)الطفرة يمكسسا من الكشف عسها في 
 .الحديث في مراحل حياتهم األولى
 مل دم من 3-2 وإلتمام هذه الدراسة يتطمب من عائمة المريض تعبئة االستبيان بدقة والموافقة عمى سحب 
المريض، وأسا بدوري سوف أقوم بفحص هذه العيسة بطرق جيسية دقيقة ومتطورة بمعمل الوراثة في الجامعة اإلسالمية بمساعدة 
البروفيسور فضل الشريف، وسيتم تزويد العائالت بستائج الفحوصات المخبرية، مع العمم بأن ستائج الفحوصات والمعمومات 
. التي سوف يتضمسها االستبيان سوف تستخدم لمغرض البحثي فقط ولن يتم سشرها بأي صورة من الصور
 :-إذا وافق ولي األمر  :مالحظة
 . فسرجو مسه التوقيع أسفل الصفحة .1
 .    تعبئة اإلستباسة المرفقة .2












Non-syndromic Autosomal Recessive Deafness 
  
1. Date: ……\......\2013 
 
2. Patient name:………………………………………… Age: ………… 
 
3. Address of contact guardian (Mobile No):…………............................. 
 
4. Gender:                        Male               Female 
 
5. Educational Level:       
   Primary         Preparatory      Secondary      University 
 
6. Marital status:            Single        Married 
 
7. Geographical area:     North         centre      Gaza city     South 
 
8. Number of patient's male sibs who are deaf:  ………………………………  
 
9. Number of patient's female sibs who are deaf:........................................... 
 
10.  Number of patient's male sibs with normal hearing:.................................... 
 
11.  Number of patient's female sibs with normal hearing:.................................... 
 
12.  Is there some relationship (Consanguinity) between the patient’s parents? 
                 No 
            Yes, what is the kind of relationship?………………… 
 
13.  Do both parents have normal hearing?     
        Yes            
              No, any one of the parents is deaf?  Mother    Father  Both                     
53 
 
14. Is there a relevant family history in the family of the Father?   
             Yes                 No 
 
15. Is there a relevant family history in the family of the mother? 
             Yes                 No 
 
16. Has the deafness been present since birth? 
             Yes         
              No, how long have you had a problem with deafness:……………….. 
 
17. Is there any event that preceded the deafness? 
              No 
              Yes,          Swimming           
                                   Showering     
                                   Noise exposure  
                                   Long term drug use (e.g., Aminoglycosides)          
                                   Trauma 
                                   Others  
 
18. Is there a recent or past episode of diseases or infection? 
          No 
           Yes,        Viral infection:    Mumps     Measles   Smallpox    
                                Meningitis 
                                Diabetes 
                             Others…………………………  
 
19. Is there any event during mother’s pregnancy? 
           No 
           Yes,           Administration of  drugs                 
                                  Surgery or  exposure to anesthesia     
                                  Accident              
                                  Infection 







20. Is there any event during mother’s delivery? 
           No 
          Yes,       Premature delivery           
                              Low birth weight infant              
                              Lack of oxygen during delivery 
                              Difficulty during delivery  
                            Others…………………………. 
 
21. What birth control method does the family use? 
......................................................................................................... 
 
 
 
 
